ORTHOGEL Trademark

Trademark Overview


On Thursday, October 10, 2013, a trademark application was filed for ORTHOGEL with the United States Patent and Trademark Office. The USPTO has given the ORTHOGEL trademark a serial number of 86088613. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, April 24, 2025. This trademark is owned by Orthopedic Pharmaceuticals, Inc.. The ORTHOGEL trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements; non-prescription topical analgesics, pain relief topical preparation, and topical anesthetics

General Information


Serial Number86088613
Word MarkORTHOGEL
Filing DateThursday, October 10, 2013
Status800 - REGISTERED AND RENEWED
Status DateThursday, April 24, 2025
Registration Number4647741
Registration DateTuesday, December 2, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2014

Trademark Statements


Goods and ServicesDietary supplements; non-prescription topical analgesics, pain relief topical preparation, and topical anesthetics
Pseudo MarkORTHO GEL

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 18, 2013
Primary Code005
First Use Anywhere DateSaturday, August 10, 2002
First Use In Commerce DateSunday, August 25, 2002

Trademark Owner History


Party NameOrthopedic Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTampa, FL 33619

Party NameOrthopedic Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTampa, FL 33619

Party NameOrthopedic Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTampa, FL 33619

Trademark Events


Event DateEvent Description
Monday, January 27, 2014NON-FINAL ACTION WRITTEN
Monday, October 14, 2013NEW APPLICATION ENTERED
Friday, October 18, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 19, 2013NOTICE OF PSEUDO MARK E-MAILED
Monday, January 27, 2014ASSIGNED TO EXAMINER
Monday, January 27, 2014NON-FINAL ACTION E-MAILED
Monday, January 27, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2014ASSIGNED TO LIE
Wednesday, August 13, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 5, 2014TEAS PETITION TO REVIVE RECEIVED
Tuesday, August 5, 2014PETITION TO REVIVE-GRANTED
Tuesday, August 5, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 5, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 5, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 5, 2014NOTICE OF REVIVAL - E-MAILED
Wednesday, August 6, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 27, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 16, 2014PUBLISHED FOR OPPOSITION
Monday, July 6, 2020TEAS SECTION 8 & 15 RECEIVED
Tuesday, September 29, 2020REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 29, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, September 16, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014REGISTERED-PRINCIPAL REGISTER
Monday, December 2, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 14, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 2, 2024TEAS SECTION 8 & 9 RECEIVED
Thursday, April 24, 2025REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, December 2, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 24, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 24, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 24, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED